Advisors Asset Management, Inc. Alkermes Plc. Transaction History

Advisors Asset Management, Inc.

  • $5.1 Billion
  • Q1 2025

A detailed history of Advisors Asset Management, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 17,460 shares of ALKS stock, worth $543,704. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,460
Previous 14,144 23.44%
Holding current value
$543,704
Previous $406,000 41.87%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$28.08 - $36.0 $93,113 - $119,376
3,316 Added 23.44%
17,460 $576,000
Q4 2024

Feb 10, 2025
BUY
$25.7 - $31.46 $102,440 - $125,399
3,986 Added 39.24%
14,144 $406,000
Q3 2024

Nov 08, 2024
BUY
$23.01 - $28.55 $40,750 - $50,562
1,771 Added 21.12%
10,158 $284,000
Q2 2024

Aug 14, 2024
SELL
$23.21 - $27.24 $498,991 - $585,632
-21,499 Reduced 71.94%
8,387 $202,000
Q1 2024

May 14, 2024
BUY
$26.4 - $32.56 $129,122 - $159,250
4,891 Added 19.57%
29,886 $809,000
Q4 2023

Feb 14, 2024
SELL
$23.37 - $28.68 $18,368 - $22,542
-786 Reduced 3.05%
24,995 $693,000
Q2 2023

Aug 14, 2023
SELL
$28.34 - $33.63 $19,951 - $23,675
-704 Reduced 2.66%
25,781 $806,000
Q1 2023

May 12, 2023
SELL
$25.31 - $29.02 $21,412 - $24,550
-846 Reduced 3.1%
26,485 $746,000
Q3 2022

Nov 08, 2022
BUY
$22.0 - $31.87 $74,734 - $108,262
3,397 Added 18.02%
22,249 $497,000
Q2 2022

Aug 08, 2022
BUY
$26.4 - $30.54 $497,692 - $575,740
18,852 New
18,852 $562,000
Q3 2019

Nov 14, 2019
SELL
$19.51 - $24.28 $35,000 - $43,558
-1,794 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$21.47 - $37.33 $29,650 - $51,552
-1,381 Reduced 43.5%
1,794 $40,000
Q1 2019

May 15, 2019
SELL
$28.4 - $36.49 $40,526 - $52,071
-1,427 Reduced 31.01%
3,175 $116,000
Q4 2018

Jan 31, 2019
SELL
$27.94 - $44.61 $48,028 - $76,684
-1,719 Reduced 27.2%
4,602 $136,000
Q3 2018

Nov 15, 2018
SELL
$38.6 - $46.12 $25,128 - $30,024
-651 Reduced 9.34%
6,321 $268,000
Q2 2018

Aug 22, 2018
SELL
$40.56 - $51.36 $48,509 - $61,426
-1,196 Reduced 14.64%
6,972 $287,000
Q2 2018

Aug 15, 2018
SELL
$40.56 - $51.36 $269,521 - $341,287
-6,645 Reduced 44.86%
8,168 $287,000
Q1 2018

May 15, 2018
SELL
$53.61 - $67.26 $4,932 - $6,187
-92 Reduced 0.62%
14,813 $846,000
Q4 2017

Feb 13, 2018
SELL
$47.69 - $55.39 $29,472 - $34,231
-618 Reduced 3.98%
14,905 $816,000
Q3 2017

Nov 07, 2017
BUY
$49.16 - $54.45 $763,110 - $845,227
15,523
15,523 $789,000

Others Institutions Holding ALKS

# of Institutions
410
Shares Held
177M
Call Options Held
229K
Put Options Held
436K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.11B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email